APP and Alzheimer disease: While the disease‐associated program is inherently linked to AD pathology (derived from the use of 5xFAD or APP/PS1 transgenic mice), a recent report by Mathys et al (2017) also revealed that this microglial molecular signature may proceed in a heterogeneous fashion.